http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113384604-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d2d4c1210173b53e1fbfc1a09556a84
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-35
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07
filingDate 2021-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3009fd965b1408506e4ea52cc7c6db57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e71e2d5034e99d35e8ed0a546a52e6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d306a36d5efbd6be24b939995fda5fc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b268789301207af4345c33cb23fc2cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4e50b49eeef9cfee9ec13ed0e76bc5
publicationDate 2021-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113384604-A
titleOfInvention Extraction method and application of Pseudomonas erythropolis extract for anti-tumor
abstract The invention discloses a method for extracting Pseudomonas erythropolis extract for anti-tumor, which specifically includes the following steps: Step 1, washing, drying, disassembling and crushing fruiting bodies of Pseudomonas erythropolis; Obtain flocculent Pseudomonas rosacea powder; step 2, mix the product obtained in step 1 with an organic solvent in a ratio of 1 g: 20-40 mL to obtain a mixture; extract the mixture by ultrasonic to obtain an ultrasonically treated mixture, and ultrasonically treat the mixture. The mixture was suction filtered and concentrated to obtain Pseudomonas rubra extract. The extract extracted by the invention can reverse the drug resistance of the anti-tumor chemotherapeutic drugs and improve the therapeutic effect of the anti-tumor drugs.
priorityDate 2021-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447757059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415133005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 29.